DnB Asset Management AS
- SEC CIK
- 0001456670
- Latest filing
- Aug 11, 2026
KRYS holding history
Krystal Biotech, Inc. in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,211
- Value
- $450.1K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,211 | $450.1K | <0.1% | −1,889−60.9% | Reduced | Holders |
| Q1 2026 | 3,100 | $800.8K | <0.1% | +7+0.2% | Added | Holders |
| Q4 2025 | 3,093 | $762.5K | <0.1% | +737+31.3% | Added | Holders |
| Q3 2025 | 2,356 | $415.9K | <0.1% | +625+36.1% | Added | Holders |
| Q2 2025 | 1,731 | $237.9K | <0.1% | −48−2.7% | Reduced | Holders |
| Q1 2025 | 1,779 | $320.8K | <0.1% | +242+15.7% | Added | Holders |
| Q4 2024 | 1,537 | $240.8K | <0.1% | −759−33.1% | Reduced | Holders |
| Q3 2024 | 2,296 | $417.9K | <0.1% | −57−2.4% | Reduced | Holders |
| Q2 2024 | 2,353 | $432.4K | <0.1% | +53+2.3% | Added | Holders |
| Q1 2024 | 2,300 | $409.2K | <0.1% | +2,300 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −24,500−100.0% | Sold out | Holders |
| Q1 2022 | 24,500 | $1.63M | <0.1% | −11,140−31.3% | Reduced | Holders |
| Q4 2021 | 35,640 | $2.49M | <0.1% | +35,640 | New | Holders |